Animal venoms in the production of medicines

Przemysław Szabat Szabat, Julita Poleszak, Marta Szabat, Grzegorz Boreński, Magdalena Wójcik, Joanna Milanowska


Introduction: Toxicity of animal venom is a defense mechanism known to mankind for centuries for many species of animals. We are still learning the possibilities of its use as a substance with therapeutic potential, because on its basis several drugs known and commonly used in medicine were created.
Aim of the study: To review research on the known and potential use of animal toxins as medicinal substances.
Material and method: Standard criteria were used to review literature data. Search for articles in the PubMed database was carried out using the following keywords: animal venoms, medical use, snake venoms, drugs from venom,
Description of the state of knowledge: Animal venoms have been used by man since ancient times. Due to many different mechanisms, they are able to modulate the tissue functions of the human body. In the form of already known drugs have an effect, among others. on the cardiovascular, nervous and circulatory systems. Research is also being carried out on their use in the treatment of other diseases such as autoimmune diseases and cancer.
Summary: Due to the variety of substances in animal venom and their therapeutic properties, it is possible to use them for the production of medicines. However, many studies are needed to better understand them.


animal venoms; medical use; snake venoms

Full Text:



King GF. Venoms as a platform for human drugs: translating toxins into therapeutics. Expert Opin Biol Ther. 2011; 11: 1469–1484.

Utkin YN. Animal venom studies: Current benefits and future developments. World J Biol Chem. 2015; 6(2): 28-33.

Mayor A. Greek Fire, Poison Arrows & Scorpion Bombs: Biological and Chemical Warfare in the Ancient World, New York. New York: Overlook Books; 2003.

Redi F. Osservazioni Intorno alle Vipere. Florence: All'Insegna della Stella.

Maeno H, Morimura M, Mitsuhashi S, Sawai Y, Okonogi T. Studies on Habu snake venom. 2b. Further purification and enzymic and biological activities of H alpha-proteinase. Jpn J Microbiol. 1959; 3: 277–284.

Chang CC, Lee CY. Isolation of neurotoxins from the venom of bungarus multicinctus and their modes of neuromuscular blocking action. Arch Int Pharmacodyn Ther. 1963; 144: 241–2.

Sarkar NK, Devi A. Venomous Animal and their venoms. Vol. 1 Academic Press, New York, 1986; 167.

McCleary RJ, Kini RM. Non-enzymatic proteins from snake venoms: a gold mine of pharmacological tools and drug leads. Toxicon. 2013; 62: 56–74.

Bradbury MW, Deane R. Permeability of the blood-brain barrier to lead. Neurotoxicology. 1993; 14: 131-6.

Olivera BM, Gray WR, Zeikus R, McIntosh JM, et al. Cruz, Peptide neurotoxins from fish-hunting cone snails. Science. 1985; 230(4732): 1338–1343.

McCleskey EW, Fox AP, Feldman D, et al. w-Conotoxins: direct and persistent blockade of specific types of calcium channels in neurons but not muscle, Proc. Natl. Acad. Sci. 1987; 84: 4327–4331.

Lameiras JLV, Costa OT, Moroni FT, et al. Systemic rhabdomyolysis induced by venom of freshwater stingrays Plesiotrygon iwamae and Potamotrygon motoro (Chondrichthyes–Potamotrygonidae) from the Amazon Basin. Toxicon. 2014; 77: 105–113.

Sivan G, Venketesvaran K, Radhakrishnan C. Biological and biochemical properties of Scatophagus argus venom. Toxicon. 2007; 50: 563–571.

Carlson R, Schaeffer R, Whigham H, et al. Some pharmacological properties of the venom of the scorpionfish Scorpaena guttata—II. Toxicon. 1973; 11: 167–180.

Church JE, Hodgson WC. Stonefish (Synanceia spp.) antivenom neutralises the in vitro and in vivocardiovascular activity of soldierfish (Gymnapistes marmoratus) venom. Toxicon. 2001; 39: 319–324.

Church J, Hodgson W. Dose-dependent cardiovascular and neuromuscular effects of stonefish (Synanceja trachynis) venom. Toxicon. 2000; 38: 391–407.

Hopkins BJ, Hodgson WC, Sutherland SK. Evidence for adrenergic and tachykinin activity in venom of the stonefish (Synanceja trachynis) Toxicon. 1996; 34: 541–554.

Khoo H, Hon W, Lee S, Yuen R. Effects of stonustoxin (lethal factor from Synanceja horrida venom) on platelet aggregation. Toxicon. 1995; 33: 1033–1041

Yang SH, Chien CM, Chang LS, Lin SR. Cardiotoxin III-induced apoptosis is mediated by Ca2+-dependent caspase-12 activation in K562 cells. J Biochem And Molecular Toxicology. 2008; 22: 209-18.

Rodrigues VM, Soares AM, Guerra-Sá R, Rodrigues V, Fontes MR, Giglio JR. Structural and functional characterization of neuwiedase, a nonhemorrhagic fibrin(ogen)olytic metalloprotease from Bothrops neuwiedi snake venom. Arch Biochem Biophys. 2000; 381(2): 213–224.

Chien CM, Yang SH, Chang LS, Lin SR. Involvement of both endoplasmic reticulum- and mitochondria-dependent pathways in cardiotoxin III-induced apoptosis in HL-60 cells. Clin and Experimental Pharmacology and Physiology. 2008; 35: 1059-64.

Markland FS, Shieh K, Zhou Q, et al. A novel snake venom disintegrin that inhibits human ovarian cancer dissemination and angiogenesis in an orthotopic nude mouse model. Haemostasis. 2001; 31: 183-91.

Kang IC, Lee YD, Kim DS. A novel disintegrin salmosin inhibits tumor angiogenesis. Cancer Res. 1999; 59: 3754-60.

Gao W, Starkov VG, Tsetlin VI, et al. Isolation and preliminary crystallographic studies of two new phospholipases A2 from vipera nikolskii venom. Acta crystallographica Ssection F, Structural Biol and Crystallization Commun. 2005; 61: 189-92.

Ferreira SH, Bartelt DC, Greene LJ. Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom. Biochemistry. 1970; 9: 2583–2593.

Swenson S, Markland FS., Jr Snake venom fibrin(ogen)olytic enzymes. Toxicon. 2005; 45(8): 1021–1039.

Gomes A, Choudhury SR, Saha A, et al. A heat stable protein toxin (drCT-I) from the Indian Viper (Daboia russelli russelli) venom having antiproliferative, cytotoxic and apoptotic activities. Toxicon: Official J Int Society on Toxinology. 2007; 49: 46-56.

Wang S, Xu X, Gao S, Zhu S, Rong R, Li B. Purification and partial characterization of a novel fibrinogenase from the venom of Deinagkistrodon acutus: inhibition of platelet aggregation. Protein Expr Purif. 2014; 99: 99–105.

Zychar BC, Dale CS, Demarchi DS, Gonçalves LR. Contribution of metalloproteases, serine proteases and phospholipases A2 to the inflammatory reaction induced by Bothrops jararaca crude venom in mice. Toxicon. 2010; 55(2–3): 227–234.

Cushman DW, Cheung HS, Sabo EF, Ondetti MA. Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids. Biochemistry. 1977; 16: 5484–5491.

Cushman DW, Cheung HS, Sabo EF, et al. Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids. Biochemistry. 1977; 16: 5484-5491.

Gan ZR, Gould RJ, Jacobs JW, Friedman PA, Polokoff MA. Echistatin. A potent platelet aggregation inhibitor from the venom of the viper, Echis carinatus. J Biol Chem. 1988; 263: 19827–19832.

Miljanich GP. Ziconotide: neuronal calcium channel blocker for treating severe chronic pain, Curr. Med. Chem. 2004; 11: 3029–3040.

Hashemzadeh M, Furukawa M, Goldsberry S, et al. Chemical structures and mode of action of intravenous glycoprotein IIb/IIIa receptor blockers: a review. Exp. Clin. Cardiol. 2008; 13: 192-197

Koh CY, Kini RM. From snake venom toxins to therapeutics–cardiovascular examples. Toxicon. 2012; 59: 497–506.

Furman BL. The development of Byetta (exenatide) from the venom of the Gila monster as an anti-diabetic agent. Toxicon. 2012; 59: 464–471.

Furman B, Ong WK, Pyne NJ. Cyclic AMP signaling in pancreatic islets. Adv Exp Med Biol. 2010; 654: 281–304.

You W, Choi W, Koh Y, et al. Functional characterization of recombinant batroxobin, a snake venom thrombin‐like enzyme, expressed from Pichia pastoris. Febs Letters. 2004; 571: 67-73.

Alves EM, Heneine LGD, Pesquero JL, Albuquerque MLD. Pharmaceutical Composition Containin an Apitoxin Fraction and Use Thereof. WO2011041865, 14 April 2011.

Saini S, Peterson J, Chopra A, "Melittin binds to secretary phospholipase A2 and inhibits its enzymatic activity". Biochemical and Biophysical Research Communication. 1997; 238: 436- 442.

Kocyigit A, Guler E, Kaleli S. Anti-inflammatory and antioxidative properties of honey bee venom on Freund's Complete Adjuvant-induced arthritis model in rats. Toxicon. 2019; 161: 4-11

Lee JA, Son MJ, Choi J, Jun JH, et al. Bee venom acupuncture for rheumatoid arthritis: A systematic review of randomised clinical trials. BMJ. 2014; 4: e006140.

Alves EM, Heneine LGD, Pesquero JL, Albuquerque MLD. Pharmaceutical Composition Containin an Apitoxin Fraction and Use Thereof. WO2011041865, 2011.

Momic T, Katzhendler J, Shai E, Noy E, et al. Vipegitide: a folded peptidomimetic partial antagonist of α2β1 integrin with antiplatelet aggregation activity. Drug Des Devel Ther. 2015; 9: 291–304.

Vincler M, Wittenauer S, Parker R, et al. Molecular mechanism for analgesia involving specific antagonism of a9a10 nicotinic acetylcholine receptors. Proc Natl Acad Sci. 2006; 103: 17880–17884.

Azam L, McIntosh JM. Molecular basis for the differential sensitivity of rat and human a9a10 nAChRs to a-conotoxin RgIA. J Neurochem. 2012; 122: 1137–1144.

Beeton C, Pennington MW, Norton RS, Analogs of the sea anemone potassium channel blocker ShK for the treatment of autoimmune diseases. Inflamm. Allergy Drug Targets. 2011; 10: 313-321.

van Lierop BJ, Robinson SD, Kompella SN, et al. Dicarba a-conotoxin Vc1.1 analogues with differential selectivity for nicotinic acetylcholine and GABAB receptors. ACS Chem Biol. 2013; 8: 1815–1821.

Romero HK, Christensen SB, Di Cesare Mannelli L, et al. Inhibition of a9a10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain. Proc Natl Acad Sci. 2017; 20: 30-38.

Lewis RJ. Discovery and development of the χ-conopeptide class of analgesic peptides. Toxicon. 2012; 59: 524-52.

Finol-Urdaneta RK, McArthur JR, Goldschen-Ohm MP, Gaudet R, Tikhonov DB, Zhorov BS, French RJ. Batrachotoxin acts as a stent to hold open homotetrameric prokaryotic voltage-gated sodium channels. J Gen Physiol. 2019; 151(2): 186-199.

Groeneveld GJ. Examples of Go and No-go Decisions After Rigorous Early Phase Drug Evaluation (2013)

Newman RA, Vidal JC, Viskatis LJ, et al. VRCTC310-a novel compound of purified animal toxins separates antitumor efficacy from neurotoxicity. Invest New Drugs. 1993; 11: 151-9.

Cura JE, Blanzaco DP, Brisson C, et al. Phase I and pharmacokinetics study of crotoxin (Cytotoxic PLA2, NSC624244) in Patients with advanced cancer. Clin Cancer Res. 2002; 8: 1033-41.

Schoni R. The use of snake venom-derived compounds for new functional diagnostic test kits in the field of haemostasis. Pathophysiol Haemost Thromb. 2005; 34: 234–240.

Barbosa MD, Gregh SL, Passanezi E. Fibrin adhesive derived from snake venom in periodontal surgery. J Periodontol. 2007; 78: 2026–2031.

Romero HK, Christensen SB, Di Cesare Mannelli L, et al. Inhibition of a9a10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain. Proc Natl Acad Sci. 2017.

Jin L, Boyd BJ, Larson IC, et al. Enabling noninvasive systemic delivery of the Kv1.3-blocking peptide HsTX1[R14A] via the buccal mucosa. J Pharm Sci. 2016; 105: 2173–2179.

Jin L, Zhou QT, Chan HK, et al. Pulmonary delivery of the Kv1.3-blocking peptide HsTX1[R14A] for the treatment of autoimmune diseases. J Pharm Sci. 2016; 105: 650–656.

Tanner MR, Tajhya RB, Huq R, et al. Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1 [R14A] and its PEGylated analog. Clin Immunol. 2017; 180: 45–57.

Weinstein SA, Schmidt JJ, Bernheimer AW, Smith LA. Characterization and amino acid sequences of two lethal peptides isolated from venom of Wagler’s pit viper, Trimeresurus wagleri. Toxicon. 1991; 29: 227–236.

Favreau P, Benoit E, Hocking HG, et al. A novel l-conopeptide, CnIIIC, exerts potent and preferential inhibition of NaV1.2/1.4 channels and blocks neuronal nicotinic acetylcholine receptors. Br J Pharmacol. 2012; 166: 1654–1668

McArdle JJ, Lentz TL, Witzemann V, et al. Waglerin-1 selectively blocks the e form of the muscle nicotinic acetylcholine receptor. J Pharmacol Exp Ther. 1999; 289: 543–550.

Chi V, Pennington MW, Norton RS, Tarcha EJ, et al. Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases. Toxicon. 2012; 59: 529-546

Lebrun B, Romi-Lebrun R, Martin-Eauclaire MF, et al. A four-disulphidebridged toxin, with high affinity towards voltage-gated K+ channels, isolated from Heterometrus spinnifer (Scorpionidae) venom. Biochem J. 1997; 328: 321–327.

Diochot S, Baron A, Salinas M, Douguet D, et al. Black mamba venom peptides target acid-sensing ion channels to abolish pain. Nature. 2012; 15: 552-555.

Gutierrez VP, Zambelli VO, Picolo G, et al. The peripheral L-arginine-nitric oxide-cyclic GMP pathway and ATP-sensitive K⁺ channels are involved in the antinociceptive effect of crotalphine on neuropathic pain in rats. Behav. Pharmacol. 2012; 23: 14-24.

Zambelli VO, Fernandes AC, Gutierrez VP, et al. Peripheral sensitization increases opioid receptor expression and activation by crotalphine in rats. PLoS One. 2014; 9: e90576.



  • There are currently no refbacks.

Copyright (c) 2019 © The Author(s)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Journal of Education, Health and Sport formerly Journal of Health Sciences

Declaration on the original version.

Editors indicates that the main version of the magazine is to issue a "electronic".

The journal has had 5 points in Ministry of Science and Higher Education parametric evaluation. § 8. 2) and § 12. 1. 2) 22.02.2019.

1223 Journal of Education, Health and Sport eISSN 2391-8306 7

ISSN 2391-8306 formerly ISSN: 1429-9623 / 2300-665X

Archives 2011 - 2014

PBN 2011 - 2014

POL-index 2011 - 2014

BASE 2011 - 2014

Indexed in Bases, Bazy indeksacyjne: ERIH Plus, Worldcat, PBN/POL-Index, ICI Journals Master List, Directory of Open Access Journals (DOAJ), ZBD, Ulrich's periodicals, Google Scholar, Polska Bibliografia Lekarska

US NLM = 101679844

101679844 - NLM Catalog Result - NCBI

Find a library that holds this journal:

Journal Language(s): English 

PBN Poland



Redaction, Publisher and Editorial Office

Instytut Kultury Fizycznej Uniwersytet Kazimierza Wielkiego w Bydgoszczy, Institute of Physical Education Kazimierz Wielki University in Bydgoszcz, Poland 85-091 Bydgoszcz ul. Sportowa 2 Copyright by Instytut Kultury Fizycznej UKW w Bydgoszczy  Open Access ISSN 2391-8306 formerly ISSN: 1429-9623 / 2300-665X

The journal has been approved for inclusion in ERIH PLUS.

The ERIH PLUS listing of the journal is available at

SIC Science citation index (calculated on the basis of TCI and Page Rank) 0

Russian Impact factor 0.16

Indexed in Index Copernicus Journals Master List.,p24782242,3.html

ICV 2018 = 95.95 ICV 2017 = 91.30 ICV 2016 = 84.69 ICV 2015 = 93.34 ICV 2014 = 89.51 Standardized Value: 8.27 ICV 2013: 7.32 ICV 2012: 6.41 ICV 20115.48

The InfoBase Index IBI Factor for the year 2015 is 3.56 in InfoBase


Universal Impact Factor 1.78 for year 2012. (

Indexed in Polish Scholarly Bibliography (PBN) (PBN Polska Bibliografia Naukowa) (

is a portal of the Polish Ministry of Science and Higher Education, collecting information on publications of Polish scientists and on Polish and foreign scholarly journals. Polish Scholarly Bibliograhpy is a part of POL-on - System of Information on Higher Education. It is operated by the Interdisciplinary Centre for Mathematical and Computational Modelling, University of Warsaw.

Indexed in Russian Sciences Index Российский индекс научного цитирования (РИНЦ)

Indexed in Arianta Polish scientific and professional electronic journals Aneta Drabek i Arkadiusz Pulikowski